Fundraising September 15, 2024 – October 1, 2024 About fundraising

CM082 , a novel angiogenesis inhibitor,...

CM082 , a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non‐small cell lung cancer in vitro and in vivo

Zhang, Kun, Wang, Lili, Wei, Aili, Jia, Xinfei, Liu, Xiaoqing
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Thoracic Cancer
DOI:
10.1111/1759-7714.13430
Date:
May, 2020
File:
PDF, 4.14 MB
2020
Conversion to is in progress
Conversion to is failed